Exploring the opioid system by gene knockout

Progress in Neurobiology

Volumn 66, Issue 5, 2002, Pages 285-306

  Kieffer, Brigitte L ^a   Gavériaux Ruff, Claire ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; 4 AMINOBUTYRIC ACID; ANESTHETIC AGENT; APOMORPHINE; BETA ENDORPHIN; BREMAZOCINE; CANNABINOID; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; DIPRENORPHINE; DYNORPHIN DERIVATIVE; ENADOLINE; ENDORPHIN DERIVATIVE; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NALTRINDOLE; OPIATE; OPIATE RECEPTOR; PROOPIOMELANOCORTIN; UNINDEXED DRUG;

BEHAVIOR; EMOTION; GENE MUTATION; GENE TARGETING; GENETIC CODE; HUMAN; IN VIVO STUDY; KNOCKOUT GENE; KNOCKOUT MOUSE; LOCOMOTION; LONG TERM POTENTIATION; MUTANT; NOCICEPTION; NONHUMAN; PAIN; PHENOTYPE; PRECURSOR; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; STRESS;

ANIMALS; BRAIN CHEMISTRY; MICE; MICE, KNOCKOUT; OPIOID PEPTIDES; RECEPTORS, OPIOID;

EID: 0036095186     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(02)00008-4     Document Type: Review

References (114)

1. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide
2. Molecular and neuroanatomical properties of the endogenous opioid systems: Implications for the treatment of opiate addiction
3. Opioids and the neuroendocrine control of reproduction
4. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation
5. Morphine self-administration in mu-opioid receptor-deficient mice
6. Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice
7. An autoradiographic study in mu-opioid receptor knockout mice
8. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1
9. Selectivity of ligands for opioid receptors
10. Effects of opioids on the spontaneous behaviour of animals
11. Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice
12. Orphanin FQ/nociceptin: A role in pain and analgesia, but so much more
13. Heterodimerization of G-protein-coupled receptors: Pharmacology, signaling and trafficking
14. Non-peptide delta opioid agonists and antagonists
15. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations
16. Cannabinoid receptors and their endogenous agonists
17. The δ- and μ-opioid receptor-deficient mice exhibit opposing alterations of emotional responses
18. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice
19. Immunosuppression by delta-opioid antagonist naltrindole: Delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a non-opioid activity
20. Opioid receptors: Gene structure and function
21. Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor gene
22. Motivational effects of cannabinoids are mediated by mu- and kappa-opioid receptors
23. Intravenous self-administration of ethanol in beta-endorphin-deficient mice
24. Ethanol oral self-administration is increased in mutant mice with decreased beta-endorphin expression
25. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice
26. Targeted mutagenesis of the murine opioid system
27. Endogenous opioid systems and alcohol addiction
28. Th2-dependent airway eosinophilia is regulated by preproenkephalin
29. 35S]GTPgammaS binding in mu receptor knockout mice
30. Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice
31. Involvement of mu-opioid receptors in potentiation of apomorphine-induced climbing behavior by morphine: Studies using mu-opioid receptor gene knockout mice
32. Differential effects of morphine, DPDPE, and U50,488 on apomorphine-induced climbing behavior in μ-opioid receptor knockout mice
33. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides
34. Opioids: First lessons from knockout mice
35. Opioid receptors: From genes to mice
36. Molecular mechanism of opioid dependence by using knockout mice
37. Enkephalin release and opioid receptor activation does not mediate the antinociceptive or sedative/hypnotic effects of nitrous oxide
38. No heroin or morphine 6-beta-glucuronide analgesia in mu-opioid receptor knockout mice
39. Quantitative autoradiographic mapping of μ-, δ- and κ-opioid receptors in knockout mice lacking the μ-opioid receptor gene
40. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin
41. Drug abuse: Hedonic homeostatic dysregulation
42. The anxiolytic effect of acute ethanol or diazepam exposure is unaltered in &mgr;-opioid receptor knockout mice
43. Stress-induced analgesia in mu-opioid receptor knockout mice reveals normal function of the delta-opioid receptor system
44. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
45. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice
46. Loss of plasma glucose lowering response to cold stress in opioid mu-receptor knockout diabetic mice
47. Mu-opioid receptor knockout mice: Effects on ligand-induced analgesia and morphine lethality
48. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene
49. Anatomical distribution of opioid receptors in mammalian: An overview
50. Pharmacological and biochemical interactions between opioids and cannabinoids
51. Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice
52. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene
53. Activity of the δ-opioid receptor is partially reduced while activity of the κ-receptor is maintained in mice lacking the μ-receptor
54. Lack of expression of long term potentiation in the dentate gyrus but not in the CA1 region of the hippocampus of mu-opioid receptor-deficient mice
55. Evidence for central opioid receptors in the immunomodulatory effects of morphine: Review of potential mechanism(s) of action
56. The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice
57. Disparate spinal and supraspinal opioid antinociceptive responses in beta-endorphin-deficient mutant mice
58. Specific activation of the mu-opioid receptor (MOR) by endomorphin 1 and endomorphin 2
59. Respiratory function in adult mice lacking the mu-opioid receptor: Role of delta-receptors
60. Opioids in the etiology and treatment of psychiatric disorders
61. Evidence for the existence of the beta-endorphin-sensitive epsilon-opioid receptor in the brain: The mechanisms of epsilon-mediated antinociception
62. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice
63. Overexpression of dynamin is induced by chronic stimulation of mu- but not delta-opioid receptors: Relationships with mu-related morphine dependence
64. Opioid pharmacology of acute and chronic pain
65. Comparison of G-protein activation in the brain by m-, d-, and k-opioid receptor agonists in m-opioid receptor knockout mice
66. Effects of morphine on pentobarbital-induced responses in mu-opioid receptor knockout mice
67. Pharmacological mechanisms of opioid analgesics
68. Psychomimesis mediated by κ opiate receptors
69. Opioid systems and stress
70. Enhanced delta-opioid receptor-mediated antinociception in mu-opioid receptor-deficient mice
71. Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: Involvement of κ opioid receptors
72. Female preproenkephalin-knockout mice display altered emotional responses
73. Development of delta opioid peptides as non-addicting analgesics
74. The mu-opioid receptor knockout mice do not self-administer alcohol
75. Increased ethanol self-administration in delta-opioid receptor knockout mice
76. Allosteric coupling among opioid receptors: Evidence for an opioid receptor complex
77. Mu-Opioid receptor-knockout mice: The role of mu-opioid receptor in gastrointestinal transit
78. Mu-Opioid receptor-knockout mice: Role of mu-opioid receptor in morphine mediated immune functions
79. Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice
80. Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis
81. Retention of heroin and morphine-6B-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1
82. Generation of dynorphin knockout mice
83. Evidence for opioid receptors on cells involved in host defense and the immune system
84. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression
85. Endogenous opioid regulation of hippocampal function
86. Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U50,488H and attenuates morphine withdrawal
87. 3H] bremazocine binding in single and combinatorial opioid receptor knockout mice
88. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knockout mice
89. Quantitative autoradiography of μ-, δ- and κ1 opioid receptors in kappa-opioid receptor knockout mice
90. Autoradiographic mapping of the opioid receptor-like 1 (ORL-1) receptor in the brains of μ-, δ- or κ-opioid receptor knockout mice
91. Effect of the &mgr;-opioid agonist DAMGO on medial basal hypothalamic neurons in beta-endorphin knockout mice
92. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia
93. Visceral chemical nociception in mice lacking mu-opioid receptors: Effects of morphine, SNC80 and U50,488
94. &mgr Opiate receptor gene dose effects on different morphine actions. Evidence for differential in vivo &mgr receptor reserve
95. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway
96. Opioid and opiate immunoregulatory processes
97. Peripheral opioid analgesia
98. Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model
99. Altered hematopoiesis, behavior, and sexual function in μ opioid receptor-deficient mice
100. δ-opioid receptor subtypes and cross talk with μ-receptors
101. Involvement of the opioid system in the anxiolytic effect of diazepam in mice
102. Endogenous opiates: 1999
103. Recent findings on the mechanism of action of morphine
104. Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knockout mice
105. Opioids, reward and addiction: An encounter of biology, psychology and medicine
106. Pronociceptive actions of dynorphin maintain chronic neuropathic pain
107. Stress-induced responses and multiple opioid systems in the brain
108. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
109. A potent and selective endogenous agonist for the μ-opiate receptor
110. Opioid receptor types and subtypes: The δ receptor as a model
111. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice
112. Absence of delta-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice